|
US37913A
(en)
|
|
1863-03-17 |
|
Improvement in sewing-machines |
|
US146439A
(en)
|
|
1874-01-13 |
|
Improvement in pruning-shears |
|
US37914A
(en)
|
|
1863-03-17 |
|
Improved automatic nose-bag |
|
US13294A
(en)
|
|
1855-07-17 |
|
Improved apparatus for cooling repeating fire-arms |
|
DE1617477U
(de)
|
1950-09-27 |
1950-12-14 |
Heinrich Dressel |
Radhalter fuer raeder, beispielsweise fuer kinderwagen und kleinfahrzeuge.
|
|
US3776938A
(en)
*
|
1958-05-28 |
1973-12-04 |
S Bergstrom |
Dihydro-pge1
|
|
US3839409A
(en)
*
|
1958-05-28 |
1974-10-01 |
Kemiska Inst Karolinska I |
Pge3 esters and alkanoates
|
|
US3069322A
(en)
*
|
1958-05-28 |
1962-12-18 |
Bergstrom Sune |
Pge and pgf
|
|
US3776939A
(en)
*
|
1958-05-28 |
1973-12-04 |
S Bergstrom |
Dihydro-pgf1a
|
|
DE1801750U
(de)
|
1959-07-07 |
1959-12-10 |
H L Wahrendorf Betonwerk |
Trog zur aufnahme des weichengestaenges von eisenbahngleisen.
|
|
US3382248A
(en)
*
|
1965-11-01 |
1968-05-07 |
Upjohn Co |
6-amino-4, 5-di(substituted amino)-1, 2-dihydro-1-hydroxy-2-iminopyrimidines
|
|
US3435053A
(en)
*
|
1966-06-06 |
1969-03-25 |
Upjohn Co |
Cyclopenta(b)pyrans
|
|
US3524867A
(en)
*
|
1966-06-06 |
1970-08-18 |
Upjohn Co |
Process for producing cyclopenta (b)pyrans
|
|
US3538120A
(en)
|
1967-05-22 |
1970-11-03 |
Ciba Geigy Corp |
Cyclopentyl-alkanoic acids
|
|
US3636120A
(en)
|
1967-10-09 |
1972-01-18 |
Upjohn Co |
Prostaglandin e primary alcohols
|
|
GB1285371A
(en)
|
1968-08-29 |
1972-08-16 |
Upjohn Co |
Improvements in or relating to therapeutic methods using prostaglandins
|
|
GB1251750A
(de)
|
1968-11-12 |
1971-10-27 |
|
|
|
DE1910561A1
(de)
|
1969-03-01 |
1970-09-10 |
Herten Dr Med Kurt |
Mittel zur Verhuetung von Haarausfall
|
|
BE755555A
(fr)
*
|
1969-09-02 |
1971-03-01 |
Richardson Merrell Inc |
Derives de quinoxaline
|
|
US3882241A
(en)
*
|
1969-12-01 |
1975-05-06 |
Upjohn Co |
Use of prostaglandins E and F for prevention of pregnancy in humans
|
|
US3896156A
(en)
*
|
1970-06-30 |
1975-07-22 |
Upjohn Co |
Dihydroprostaglandin e, analogs
|
|
IT1012505B
(it)
|
1970-09-28 |
1977-03-10 |
Imes C Spa |
Estratto di ricci di mare
|
|
BE791369A
(fr)
|
1971-11-16 |
1973-05-14 |
American Cyanamid Co |
Cyanurates de tris-(meta-hydroxybenzyle) faisant l'objet d'un empechement sterique et utilisables comme anti-oxydants
|
|
US3798275A
(en)
|
1972-04-05 |
1974-03-19 |
Ciba Geigy Corp |
Etherified mercapto-methoxyamines
|
|
US4304907A
(en)
|
1972-05-10 |
1981-12-08 |
The Upjohn Company |
Bicyclo lactone intermediates for prostaglandin analogs
|
|
US3974213A
(en)
|
1972-07-13 |
1976-08-10 |
Pfizer Inc. |
13,14-Dihydro-15-substituted-ω-pentanorprostaglandins
|
|
US4011262A
(en)
*
|
1972-07-13 |
1977-03-08 |
Pfizer Inc. |
13,14-Dihydro-15-substituted-ω-pentanorprostaglandins of the two series
|
|
US3882245A
(en)
*
|
1972-11-01 |
1975-05-06 |
Upjohn Co |
Use of prostaglandins in combating shock
|
|
DD118856A5
(de)
|
1972-11-08 |
1976-03-20 |
|
|
|
US4024179A
(en)
*
|
1972-11-08 |
1977-05-17 |
Pfizer Inc. |
Substituted ω-pentanorprostaglandins
|
|
IL50310A
(en)
|
1972-11-08 |
1977-08-31 |
Pfizer |
Dimethyl ketophosphonates
|
|
US4152527A
(en)
|
1972-11-08 |
1979-05-01 |
Pfizer Inc. |
15-Substituted-ω-pentanorprostaglandins
|
|
US3984424A
(en)
|
1972-11-08 |
1976-10-05 |
Pfizer Inc. |
P-biphenyl esters of 15-substituted-ω-pentanorprostaglandins
|
|
JPS49101356U
(de)
|
1972-12-20 |
1974-08-31 |
|
|
|
JPS5320995Y2
(de)
|
1972-12-23 |
1978-06-02 |
|
|
|
JPS5720305B2
(de)
|
1973-02-28 |
1982-04-27 |
|
|
|
US3984455A
(en)
*
|
1973-07-16 |
1976-10-05 |
The Upjohn Company |
Prostaglandin E1 analogs
|
|
FR2239458A1
(en)
|
1973-07-31 |
1975-02-28 |
Aries Robert |
Prostaglandin amides - with antilipolytic, gonadotrophic, luteolytic, hypotensive and other activities associated with prostaglandins
|
|
DE2365101A1
(de)
|
1973-12-21 |
1975-07-10 |
Schering Ag |
Neue prostansaeurederivate und verfahren zu ihrer herstellung
|
|
US3931282A
(en)
|
1974-02-21 |
1976-01-06 |
Syntex (U.S.A.) Inc. |
11α-Hydroxymethyl prostaglandins
|
|
US3928588A
(en)
*
|
1974-02-22 |
1975-12-23 |
Upjohn Co |
Method of reducing the undesirable gastrointestinal effects of prostaglandin synthetase inhibitors
|
|
US4069885A
(en)
*
|
1974-03-27 |
1978-01-24 |
Klockner-Humboldt-Deutz Aktiengesellschaft |
Tractor-implement arrangement for establishing frictional engagement therebetween
|
|
DE2416193C2
(de)
*
|
1974-04-03 |
1985-08-14 |
Hoechst Ag, 6230 Frankfurt |
Prostaglandin-Analoge, Verfahren zu ihrer Herstellung sowie ihre Verwendung als cytoprotektives Mittel
|
|
GB1458315A
(en)
|
1974-04-22 |
1976-12-15 |
Ici Ltd |
Prostanoic acid derivatives
|
|
DE2460990A1
(de)
|
1974-12-21 |
1976-07-01 |
Hoechst Ag |
Neue prostaglandin-analoga und verfahren zu ihrer herstellung
|
|
GB1507211A
(en)
*
|
1975-02-14 |
1978-04-12 |
Ono Pharmaceutical Co |
Prostaglandin analogues
|
|
US3934013A
(en)
|
1975-02-21 |
1976-01-20 |
Syntex (U.S.A.) Inc. |
Pharmaceutical composition
|
|
US4217360A
(en)
*
|
1975-02-27 |
1980-08-12 |
Schering Aktiengesellschaft |
Novel 1,3-benzodioxaneprostanoic acid derivatives and process for the preparation thereof
|
|
GB1506816A
(en)
|
1975-03-31 |
1978-04-12 |
Upjohn Co |
Prostaglandins
|
|
DE2517771A1
(de)
*
|
1975-04-18 |
1976-10-28 |
Schering Ag |
Neue prostaglandin-acetylen-analoga und verfahren zu ihrer herstellung
|
|
GB1520522A
(en)
|
1975-06-16 |
1978-08-09 |
Ono Pharmaceutical Co |
16-methyleneprostaglandins
|
|
ES449162A1
(es)
|
1975-06-23 |
1977-12-16 |
Syntex Inc |
Un procedimiento para la preparacion de un compuesto racemi-co u 8r-antimerico.
|
|
US4005133A
(en)
|
1975-10-14 |
1977-01-25 |
The Upjohn Company |
PGF2.sub.α, L-Arginine salt
|
|
US4128577A
(en)
|
1975-12-29 |
1978-12-05 |
The Upjohn Company |
15-Methyl- and 16-phenoxy-PGF2 α, amides
|
|
US4158667A
(en)
*
|
1976-02-04 |
1979-06-19 |
The Upjohn Company |
6-Keto PGF analogs
|
|
US4596812A
(en)
*
|
1976-05-24 |
1986-06-24 |
The Upjohn Company |
Methods and solutions for treating male pattern alopecia
|
|
US4139619A
(en)
*
|
1976-05-24 |
1979-02-13 |
The Upjohn Company |
6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth
|
|
US4051238A
(en)
|
1976-06-03 |
1977-09-27 |
The Upjohn Company |
Treatment of genital tract diseases of domestic animals with prostaglandins
|
|
US4268522A
(en)
|
1976-06-14 |
1981-05-19 |
Pfizer Inc. |
13,14-Dihydro-15-alkenyl- and 13,14-dihydro-15-alkynyl prostaglandins and analogs thereof
|
|
DE2635985A1
(de)
*
|
1976-08-06 |
1978-02-09 |
Schering Ag |
Prostansaeurederivat und verfahren zu ihrer herstellung
|
|
DE2737807A1
(de)
|
1976-08-27 |
1978-03-09 |
Pfizer |
C tief 1 -p-biphenylester von omega-pentanorprostaglandinen
|
|
DE2737808A1
(de)
|
1976-08-27 |
1978-03-16 |
Pfizer |
2-substituierte aryl-heterocyclische omega-pentanorprostaglandine
|
|
US4499293A
(en)
*
|
1976-09-22 |
1985-02-12 |
The Upjohn Company |
PGI2 Salts
|
|
US4123441A
(en)
*
|
1976-09-22 |
1978-10-31 |
The Upjohn Company |
Enlarged-hetero-ring prostacyclin analogs
|
|
US4089885A
(en)
*
|
1976-11-05 |
1978-05-16 |
American Home Products Corporation |
Prostaglandin derivatives
|
|
US4171331A
(en)
*
|
1978-06-05 |
1979-10-16 |
Miles Laboratories, Inc. |
1 And 2-substituted analogues of certain prostaglandins
|
|
US4178457A
(en)
|
1978-07-10 |
1979-12-11 |
Syntex (U.S.A.) Inc. |
(dl)-16-Phenoxy- and 16-substituted phenoxy-9-keto prostatrienoic acid derivatives and processes for the production thereof
|
|
US4206151A
(en)
|
1978-12-21 |
1980-06-03 |
American Cyanamid Company |
15-Deoxy-16-hydroxy-16-vinyl or cyclopropyl prostan-1-ols of the E, A and F series
|
|
US4311707A
(en)
*
|
1979-02-12 |
1982-01-19 |
American Cyanamid Company |
Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
|
|
GB2048254B
(en)
|
1979-04-02 |
1983-05-25 |
Upjohn Co |
19,20 -didehydro-19-hydroxy and 19-oxo-prostaglandin derivatives
|
|
US4225508A
(en)
*
|
1979-07-05 |
1980-09-30 |
The Upjohn Company |
19-Hydroxy-PGI2 compounds
|
|
US4225507A
(en)
*
|
1979-07-05 |
1980-09-30 |
The Upjohn Company |
19-Hydroxy-19-methyl-PGI2 compounds
|
|
US4296504A
(en)
|
1980-07-07 |
1981-10-27 |
Lawson Daniel C |
Toilet seat lock
|
|
JPH0222226Y2
(de)
|
1981-02-04 |
1990-06-14 |
|
|
|
US4621100A
(en)
*
|
1981-09-25 |
1986-11-04 |
The Upjohn Company |
Treatment of osteoporosis with prostaglandins
|
|
US4543353A
(en)
|
1981-11-27 |
1985-09-24 |
Farmitalia Carlo Erba S.P.A. |
Ester and amide derivatives of 13,14-didehydro prostaglandins
|
|
US4599353A
(en)
*
|
1982-05-03 |
1986-07-08 |
The Trustees Of Columbia University In The City Of New York |
Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
|
|
US4912235A
(en)
|
1983-12-22 |
1990-03-27 |
Syntex (U.S.A.) Inc. |
Processes and intermediates for making 16-phenoxy- and 16-substituted phenoxy-prostatrienoic acid derivatives and their stereoisomers
|
|
EP0187854A4
(de)
|
1984-07-13 |
1987-01-22 |
Gail S Bazzano |
Substituierte pyrimidinoxide, einsetzbar zur haarwachsanregung.
|
|
EP0170258B1
(de)
|
1984-07-31 |
1989-12-27 |
Syntex (U.S.A.) Inc. |
11-Substituierte-16-phenoxy und 16-phenoxysubstituierte Prostatriensäurederivate
|
|
JPS61126069A
(ja)
*
|
1984-11-21 |
1986-06-13 |
Res Dev Corp Of Japan |
プロスタグランジン誘導体
|
|
JPS61218510A
(ja)
*
|
1985-03-22 |
1986-09-29 |
Dai Ichi Seiyaku Co Ltd |
毛髪用剤
|
|
US4757089A
(en)
|
1985-06-14 |
1988-07-12 |
Massachusetts Eye And Ear Infirmary |
Increasing aqueous humor outflow
|
|
US5863948A
(en)
|
1985-06-14 |
1999-01-26 |
Massachusetts Eye And Ear Infirmary |
Increasing aqueous humor outflow
|
|
US4704386A
(en)
*
|
1985-08-29 |
1987-11-03 |
G. D. Searle & Co. |
8-chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid, 2-[(phenylsulfinyl-, and phenylsulfonyl)alkanoyl]hydrazides
|
|
US4883819A
(en)
|
1986-07-31 |
1989-11-28 |
The Trustees Of Columbia University In The City Of New York |
Use of A, B and C prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma
|
|
US4889845A
(en)
*
|
1986-06-09 |
1989-12-26 |
American Cyanamid Company |
Vehicle for topical application of pharmaceuticals
|
|
FI872552A7
(fi)
*
|
1986-06-09 |
1987-12-10 |
American Cyanamid Co |
Paikallisesti käytettävä prostaglandiinikoostumus.
|
|
US5041439A
(en)
|
1986-06-13 |
1991-08-20 |
The Procter & Gamble Company |
Penetrating topical pharmaceutical compositions
|
|
US5663203A
(en)
*
|
1986-09-11 |
1997-09-02 |
Schering Aktiengesellschaft |
Agents containing prostacyclin derivatives for topical application
|
|
US5500230A
(en)
*
|
1987-01-23 |
1996-03-19 |
The General Hospital Corporation |
Method for treatment of glaucoma with nitrogen containing guanylate cyclase activators
|
|
US5219885A
(en)
*
|
1987-02-16 |
1993-06-15 |
Froelich Juergen |
Prostaglandin E1 derivatives as pharmaceutically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration
|
|
US4952581A
(en)
|
1987-04-03 |
1990-08-28 |
The Trustees Of Columbia University In The City Of New York |
Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
|
|
US5591887A
(en)
*
|
1987-04-30 |
1997-01-07 |
R-Tech Ueno, Ltd. |
Prostaglandins of the F series
|
|
GB8713747D0
(en)
|
1987-06-12 |
1987-07-15 |
Unilever Plc |
Skin treatment composition
|
|
ES2052735T3
(es)
|
1987-09-18 |
1994-07-16 |
R Tech Ueno Ltd |
Un metodo para producir un agente hipotensor ocular.
|
|
US5166178B1
(en)
|
1987-09-18 |
1998-07-21 |
R Tech Ueno Ltd |
Ocular hypotensive agents
|
|
US5296504A
(en)
|
1988-09-06 |
1994-03-22 |
Kabi Pharmacia |
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
|
|
WO1990002553A1
(en)
|
1988-09-06 |
1990-03-22 |
Pharmacia Ab |
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
|
|
US5321128A
(en)
|
1988-09-06 |
1994-06-14 |
Kabi Pharmacia Ab |
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
|
|
US6187813B1
(en)
|
1990-04-10 |
2001-02-13 |
Pharmacia & Upjohn Aktiebolag |
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
|
|
US5194429A
(en)
*
|
1988-10-01 |
1993-03-16 |
K.K. Ueno Seiyaku Oyo Kenkyujo |
Ocular hypotensive agents
|
|
US4968812A
(en)
|
1989-06-23 |
1990-11-06 |
Shell Oil Company |
Spirolactonelactams
|
|
JPH0737389B2
(ja)
|
1989-08-29 |
1995-04-26 |
久光製薬株式会社 |
プロスタグランジンｅ１含有の軟膏剤
|
|
CA1339132C
(en)
|
1989-09-12 |
1997-07-29 |
Johan W. Stjernschantz |
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
|
|
CA2030345C
(en)
|
1989-11-22 |
1998-12-08 |
Ryuji Ueno |
Use of 15-keto-prostaglandin compound for improvement of encephalic function
|
|
JPH0627942Y2
(ja)
|
1989-12-14 |
1994-07-27 |
松下電器産業株式会社 |
ヒューズホルダー付コンデンサー
|
|
WO1991013207A1
(en)
|
1990-02-21 |
1991-09-05 |
Pulp And Paper Research Institute Of Canada |
POLY-β-HYDROXYALKANOATES FOR USE IN FIBRE CONSTRUCTS AND FILMS
|
|
TW224942B
(de)
|
1990-04-04 |
1994-06-11 |
Adka Ueno Kk |
|
|
US5063057A
(en)
*
|
1990-09-26 |
1991-11-05 |
Elizabeth Arden Co., Division Of Conopco, Inc. |
Cosmetic capsules
|
|
US5302617A
(en)
|
1990-04-27 |
1994-04-12 |
Kabushikikaisha Ueno Seiyaku Oyo Kenkyuio |
Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds
|
|
DE4024347A1
(de)
|
1990-07-27 |
1992-01-30 |
Schering Ag |
Cyclopentanderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
|
|
JPH04300833A
(ja)
|
1991-03-29 |
1992-10-23 |
Green Cross Corp:The |
プロスタグランジンｅ１ 含有脂肪乳剤充填噴霧剤
|
|
US5378840A
(en)
*
|
1992-04-16 |
1995-01-03 |
G. D. Searle & Co. |
Substituted dibenzoxazepine compounds
|
|
US5312832A
(en)
|
1991-05-17 |
1994-05-17 |
Allergan, Inc. |
Ocular hypotensive 2-decarboxyl-2-acylthioalkyl prostaglandin derivatives
|
|
US5288754A
(en)
*
|
1992-02-04 |
1994-02-22 |
Allergan, Inc. |
Polar C-1 esters of prostaglandins
|
|
US5641494A
(en)
*
|
1992-03-20 |
1997-06-24 |
Janssen Pharmaceutica N.V. |
Agent for regulating the greasiness of the skin
|
|
US5578643A
(en)
*
|
1992-05-20 |
1996-11-26 |
Loyola University Of Chicago |
Protective prostaglandins for use in conjunction with chemotherapeutic agents
|
|
US5422371A
(en)
*
|
1992-05-27 |
1995-06-06 |
Arch Development Corp. |
Methods and compositions for inhibiting 5α-reductase activity
|
|
JP3102141B2
(ja)
*
|
1992-05-29 |
2000-10-23 |
東レ株式会社 |
養毛育毛剤
|
|
US5817694A
(en)
*
|
1992-06-08 |
1998-10-06 |
New Pharma International Corp. |
16-methyl-11,16-dihydroxy-9-oxoprost-2,13-dien-1-oic acid and derivatives
|
|
US5409911A
(en)
|
1992-09-11 |
1995-04-25 |
Merck & Co., Inc. |
Prostaglandin analog for treating osteoporosis
|
|
US5688819A
(en)
|
1992-09-21 |
1997-11-18 |
Allergan |
Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
|
|
US5352708A
(en)
*
|
1992-09-21 |
1994-10-04 |
Allergan, Inc. |
Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
|
|
US5834498A
(en)
*
|
1992-09-21 |
1998-11-10 |
Allergan |
Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
|
|
US5972991A
(en)
*
|
1992-09-21 |
1999-10-26 |
Allergan |
Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
|
|
ATE153855T1
(de)
|
1992-10-13 |
1997-06-15 |
Alcon Lab Inc |
Zusammensetzungen zur behandlung von glaukoma die prostaglandine und clonidinderivate enthalten
|
|
US5332730A
(en)
|
1992-10-16 |
1994-07-26 |
Allergan, Inc. |
Azido derivatives of cyclopentane heptanoic or heptenoic acid
|
|
US5340813A
(en)
*
|
1992-11-09 |
1994-08-23 |
Cell Therapeutics, Inc. |
Substituted aminoalkyl xanthine compounds
|
|
DE4238830A1
(de)
*
|
1992-11-17 |
1994-05-19 |
Anton Felder |
Verfahren zum hydraulischen Verzweigen einer offenen Strömung sowie hydraulisch arbeitende Kanalverzweigung
|
|
US5670506A
(en)
*
|
1993-04-05 |
1997-09-23 |
Cell Therapeutics, Inc. |
Halogen, isothiocyanate or azide substituted xanthines
|
|
US5395932A
(en)
*
|
1993-04-30 |
1995-03-07 |
G. D. Searle & Co. |
2,3-,4-,5-,6-,7-,8-,9- and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
|
|
US5985597A
(en)
*
|
1993-05-26 |
1999-11-16 |
Merck Frosst Canada, Inc. |
DNA encoding prostaglandin receptor EP1
|
|
WO1995000552A1
(en)
|
1993-06-25 |
1995-01-05 |
Merck Frosst Canada Inc. |
Prostaglandin receptor ep3 and dna encoding it
|
|
US5869281A
(en)
*
|
1993-06-25 |
1999-02-09 |
Merck Frosst Canada Inc. |
DNA encoding prostaglandin receptor FP
|
|
US5510383A
(en)
*
|
1993-08-03 |
1996-04-23 |
Alcon Laboratories, Inc. |
Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
|
|
US5605814A
(en)
*
|
1993-08-31 |
1997-02-25 |
Merck Frosst Canada Inc. |
DNA encoding human prostaglandin receptor EP2
|
|
US5516652A
(en)
*
|
1993-10-06 |
1996-05-14 |
Merck Frosst Canada Inc. |
DNA encoding prostaglandin receptor IP
|
|
FR2711060B1
(fr)
|
1993-10-13 |
1995-11-17 |
Oreal |
Procédé pour modifier la pousse des poils et/ou des cheveux et compositions utilisables à cet effet.
|
|
SE9303444D0
(sv)
|
1993-10-20 |
1993-10-20 |
Kabi Pharmacia Ab |
New use of prostaglandins
|
|
WO1995011033A1
(en)
|
1993-10-22 |
1995-04-27 |
Commonwealth Scientific And Industrial Research Organisation |
Polyoxometallates in the treatment of flavivirus infections
|
|
SE9303627D0
(sv)
*
|
1993-11-03 |
1993-11-03 |
Kabi Pharmacia Ab |
Method and means for prevention of cataract
|
|
US5431881A
(en)
*
|
1993-12-10 |
1995-07-11 |
Palacios; Henry J. |
Treatment of hair loss and dermatological problems
|
|
CN1046714C
(zh)
*
|
1993-12-20 |
1999-11-24 |
藤泽药品工业株式会社 |
二芳基噁唑衍生物及其制法、应用和药物组合物
|
|
US5545665A
(en)
*
|
1993-12-28 |
1996-08-13 |
Allergan |
Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
|
|
US6124344A
(en)
|
1993-12-28 |
2000-09-26 |
Allergan Sales, Inc. |
Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
|
|
US5458883A
(en)
|
1994-01-12 |
1995-10-17 |
Duke University |
Method of treating disorders of the eye
|
|
US5462968A
(en)
|
1994-01-19 |
1995-10-31 |
Allergan, Inc. |
EP2 -receptor agonists as agents for lowering intraocular pressure
|
|
ZA95627B
(en)
|
1994-01-28 |
1995-10-05 |
Procter & Gamble |
Biodegradable copolymers and plastic articles comprising biodegradable copolymers
|
|
US5476372A
(en)
|
1994-02-10 |
1995-12-19 |
Yang; Hsi-Kung |
Manual pump
|
|
SE9403158D0
(sv)
*
|
1994-09-21 |
1994-09-21 |
Pharmacia Ab |
New use of prostaglandins
|
|
US5698733A
(en)
|
1994-09-30 |
1997-12-16 |
Alcon Laboratories, Inc. |
Use of 9-deoxy prostaglandin derivatives to treat glaucoma
|
|
US5885974A
(en)
*
|
1994-12-06 |
1999-03-23 |
Michael M. Danielov |
Therapeutic methods utilizing naturally derived bio-active complexes and delivery systems therefor
|
|
KR100436812B1
(ko)
*
|
1995-01-06 |
2004-08-31 |
도레이 가부시끼가이샤 |
벤젠축합헤테로환유도체및그유도체를유효성분으로함유하는의약조성물
|
|
JP3064015B2
(ja)
*
|
1995-01-26 |
2000-07-12 |
メルク フロスト カナダ アンド カンパニー |
プロスタグランジンレセプターｄｐ
|
|
US5885766A
(en)
*
|
1995-02-17 |
1999-03-23 |
Societe L'oreal S.A. |
Method of screening of substances for their effect on the expression of mediators of inflammation in a hair follicle
|
|
FR2730811B1
(fr)
|
1995-02-17 |
1997-03-21 |
Oreal |
Procede pour diagnostiquer et/ou suivre l'evolution d'un desordre capillaire et/ou mesurer l'efficacite d'un traitement applique pour combattre un desordre capillaire
|
|
CA2221110C
(en)
|
1995-05-18 |
2009-08-04 |
Allergan |
Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension
|
|
WO1998021180A1
(en)
|
1995-06-07 |
1998-05-22 |
Alcon Laboratories, Inc. |
Conformationally rigid aryl- or heteroaryl prostaglandins for use in glaucoma therapy
|
|
AU6017396A
(en)
*
|
1995-06-26 |
1997-01-30 |
Teijin Limited |
Prostaglandins and process for producing the same
|
|
TW401408B
(en)
|
1995-07-21 |
2000-08-11 |
Fujisawa Pharmaceutical Co |
Heterocyclic compounds having prostaglandin I2 agonism
|
|
HUP9601442A3
(en)
*
|
1995-07-25 |
1999-03-29 |
Panacea Biotec Ltd |
Nes antinflammatory and analgetic pharmaceutical compositions, containing nimesulid for transdermal use, and process for producing them
|
|
US5661178A
(en)
|
1995-09-01 |
1997-08-26 |
Allergan |
Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives
|
|
US6251436B1
(en)
|
1995-09-29 |
2001-06-26 |
L.A.M. Pharmaceutical Corporation |
Drug preparations for treating sexual dysfunction
|
|
AU7271996A
(en)
|
1995-10-23 |
1997-05-15 |
Queen's University At Kingston |
Method and pharmaceutical composition for chondrostimulation with a prostaglandin (e.g. misoprostol) and tgf-beta, optionally in combination with igf-1
|
|
US6441047B2
(en)
|
1995-11-17 |
2002-08-27 |
Alcon Manufacturing Ltd.. |
Combination therapy for treating glaucoma
|
|
US5866602A
(en)
|
1995-12-22 |
1999-02-02 |
Alcon Laboratories, Inc. |
Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
|
|
AU7680096A
(en)
|
1995-12-22 |
1997-07-17 |
Alcon Laboratories, Inc. |
Combinations of dp and fp type prostaglandins for lowering iop
|
|
WO1997023226A1
(en)
|
1995-12-22 |
1997-07-03 |
Alcon Laboratories, Inc. |
Combinations of prostaglandins and miotics for lowering intraocular pressure
|
|
DE69633136T2
(de)
*
|
1995-12-22 |
2005-09-01 |
Alcon Laboratories, Inc., Fort Worth |
Substituierte tetrahydrofuran-analoge von prostaglandinen als augendrucksenkende mittel
|
|
US5814660A
(en)
|
1995-12-22 |
1998-09-29 |
Alcon Laboratories, Inc. |
9-oxa prostaglandin analogs as ocular hypotensives
|
|
AUPN814496A0
(en)
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
|
US5703108A
(en)
*
|
1996-02-28 |
1997-12-30 |
Pfizer Inc. |
Bone deposition by certain prostaglandin agonists
|
|
US5741810A
(en)
|
1996-02-29 |
1998-04-21 |
Allergan |
Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents
|
|
US5658897A
(en)
*
|
1996-04-08 |
1997-08-19 |
Allergan |
Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl phosphinyloxyalkyl or phosphonamidoalkyl as therapeutic agents
|
|
US5990168A
(en)
|
1996-04-18 |
1999-11-23 |
Alberta Cancer Board |
Methods and compositions for the treatment of ataxia telangiectasia
|
|
JP3049593B2
(ja)
*
|
1996-05-01 |
2000-06-05 |
株式会社ビメーク |
育毛・養毛剤
|
|
AU3588797A
(en)
|
1996-07-03 |
1998-01-21 |
Board Of Regents Of The University Of Oklahoma, The |
Enhancement of skin pigmentation by prostaglandins
|
|
US5792851A
(en)
*
|
1996-09-03 |
1998-08-11 |
Albert Einstin College Of Medicine Of Yeshiva University, A Division Of Yeshiva University |
Human prostaglandin transporter
|
|
ATE221048T1
(de)
|
1996-09-17 |
2002-08-15 |
Asahi Glass Co Ltd |
Fluorierte prostaglandinderivate und medikamente
|
|
US5827508A
(en)
|
1996-09-27 |
1998-10-27 |
The Procter & Gamble Company |
Stable photoprotective compositions
|
|
JP3537274B2
(ja)
|
1996-10-29 |
2004-06-14 |
鐘淵化学工業株式会社 |
生分解性を有する積層体
|
|
EP0948333A1
(de)
|
1996-11-01 |
1999-10-13 |
Alcon Laboratories, Inc. |
Verwendung einer kombination aus kohlensäure anhydrase inhibitoren und prostaglandinen zur behandlung von glaukom
|
|
JP2001504122A
(ja)
|
1996-11-12 |
2001-03-27 |
アルコン ラボラトリーズ，インコーポレイテッド |
眼圧降下剤としてのプロスタグランジン類のｃｉｓ―δ▲上４▼アナログ
|
|
AU5258698A
(en)
|
1996-11-12 |
1998-06-03 |
Alcon Laboratories, Inc. |
15-ketal prostaglandins for the treatment of glaucoma or ocular hypertension
|
|
ES2159889T3
(es)
|
1996-11-12 |
2001-10-16 |
Alcon Lab Inc |
15-fluoro prostaglandinas utilizadas como hipotensores oculares.
|
|
US6353000B1
(en)
|
1996-11-12 |
2002-03-05 |
Alcon Laboratories, Inc. |
11-halo prostaglandins for the treatment of glaucoma or ocular hypertension
|
|
TW523506B
(en)
|
1996-12-18 |
2003-03-11 |
Ono Pharmaceutical Co |
Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
|
|
ES2303341T3
(es)
|
1996-12-20 |
2008-08-01 |
Pfizer Inc. |
Prevencion y tratamiento de trastorno del esqueleto con agonistas de la prostaglandina e2 selectivos del subtipo de receptor ep2.
|
|
UA59384C2
(uk)
|
1996-12-20 |
2003-09-15 |
Пфайзер, Інк. |
Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
|
|
JPH10265454A
(ja)
*
|
1997-01-27 |
1998-10-06 |
Ono Pharmaceut Co Ltd |
３，７−ジチアプロスタン酸誘導体、それらの製造方法およびそれらを有効成分として含有する薬剤
|
|
EP1021179B1
(de)
*
|
1997-02-04 |
2004-05-12 |
Murray A. Johnstone |
Verfahren zur förderung des haarwuchses und entwicklung des haarsystems
|
|
NO317155B1
(no)
*
|
1997-02-04 |
2004-08-30 |
Ono Pharmaceutical Co |
<omega>-cykloalkyl-prostagladin-E<N>2</N>-derivater
|
|
JP4044967B2
(ja)
|
1997-02-10 |
2008-02-06 |
小野薬品工業株式会社 |
１１，１５−ｏ−ジアルキルプロスタグランジンｅ誘導体、それらの製造方法およびそれらを有効成分として含有する薬剤
|
|
KR20000065039A
(ko)
|
1997-02-27 |
2000-11-06 |
히라이 가쯔히꼬 |
폐순환 개선제
|
|
US6172109B1
(en)
|
1997-03-07 |
2001-01-09 |
Alcon Laboratories, Inc. |
13-Thia prostaglandins for use in glaucoma therapy
|
|
US6030959A
(en)
*
|
1997-04-04 |
2000-02-29 |
Monsanto Company |
Gastro-specific prodrugs
|
|
JP3217293B2
(ja)
*
|
1997-04-17 |
2001-10-09 |
株式会社アールテック・ウエノ |
発毛・育毛剤
|
|
WO1998050024A1
(en)
|
1997-05-09 |
1998-11-12 |
The Mount Sinai School Of Medicine Of The City University Of New York |
8-iso-prostaglandins for glaucoma therapy
|
|
WO1998053809A1
(en)
|
1997-05-30 |
1998-12-03 |
Merck & Co., Inc. |
Ophthalmic compositions for treating ocular hypertension
|
|
AU7349298A
(en)
|
1997-06-23 |
1999-01-04 |
Pfizer Inc. |
Prostaglandin agonists
|
|
SE9702706D0
(sv)
|
1997-07-11 |
1997-07-11 |
Pharmacia & Upjohn Ab |
Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma
|
|
AU9307198A
(en)
|
1997-09-08 |
1999-03-29 |
Abraham Pinter |
Hiv-1 gp120 v1/v2 domain epitopes capable of generating neutralizing antibo dies
|
|
AU9374198A
(en)
|
1997-09-08 |
1999-03-29 |
Idec Pharmaceuticals Corporation |
Methods for producing human antibodies in scid mice using dendritic cells
|
|
AUPO907697A0
(en)
|
1997-09-09 |
1997-10-02 |
Day, Robert Edward |
Chemical supplementation of bone
|
|
AU731153B2
(en)
*
|
1997-09-09 |
2001-03-22 |
Duke University |
Aromatic C16-C20-substituted tetrahydro prostaglandins useful as FP agonists
|
|
CA2304108A1
(en)
|
1997-09-09 |
1999-03-18 |
The Regents Of The University Of California |
Inhibition of apoptotis using prosaposin receptor agonists
|
|
ID24840A
(id)
|
1997-09-09 |
2000-08-24 |
Procter & Gamble |
Proses untuk membuat bahan antara epoksida
|
|
WO1999012899A1
(en)
*
|
1997-09-09 |
1999-03-18 |
The Procter & Gamble Company |
A process for making prostaglandin f analogs
|
|
HRP20000109A2
(en)
|
1997-09-09 |
2001-02-28 |
Hoffmann La Roche |
FRACTURE HEALING USING PTHrP ANALOGS
|
|
ES2288766T3
(es)
|
1997-09-09 |
2008-01-16 |
Curis, Inc. |
Efectos sinergicos de morfogenes op/bmp y factores neurotroficos gdnf/ngf.
|
|
EP1021402B1
(de)
|
1997-09-09 |
2005-11-23 |
Duke University |
Aromatische c16-c20-substituierte tetrahydro-prostaglandinen verwendbar wie fp agoniste
|
|
SK3412000A3
(en)
|
1997-09-09 |
2000-12-11 |
Procter & Gamble |
Method of increasing bone volume using non-naturally-occurring fp selective agonists
|
|
CN1269720A
(zh)
|
1997-09-09 |
2000-10-11 |
普罗克特和甘保尔公司 |
增加骨容量的方法
|
|
JP4619531B2
(ja)
*
|
1997-09-09 |
2011-01-26 |
デューク ユニバーシティ |
Ｆｐアゴニストとして有用な、芳香族のあるｃ１６〜ｃ２０が置換されたテトラヒドロプロスタグランジン類
|
|
WO1999012558A1
(en)
|
1997-09-10 |
1999-03-18 |
Allegheny University Of The Health Sciences |
Inhibitors of collagen assembly
|
|
ES2281136T3
(es)
|
1997-09-10 |
2007-09-16 |
Merial Ltd. |
Uso de 9a-azalidos como agentes antimicrobiales veterinarios.
|
|
DE69802815T2
(de)
|
1997-09-11 |
2002-08-01 |
Purdue Research Foundation, West Lafayette |
Durch galactosidase modifiziertes submucosales gewebe
|
|
PT1011720E
(pt)
|
1997-09-11 |
2005-04-29 |
Us Health |
Respostas de linfocitos t citotoxicos nas mucosas
|
|
EP1024821A1
(de)
|
1997-09-12 |
2000-08-09 |
Smithkline Beecham Corporation |
Neue prokaryotische polynukleotide und polypeptide und deren verwendung
|
|
EP0970697A4
(de)
|
1997-09-17 |
2001-02-21 |
Toray Industries |
Stoff zur zervikalen reifung
|
|
US6225336B1
(en)
|
1997-09-19 |
2001-05-01 |
Shionogi & Co., Ltd. |
Compounds having [2.2.1] bicyclo skeleton
|
|
UA67754C2
(uk)
|
1997-10-10 |
2004-07-15 |
Пфайзер, Інк. |
Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти)
|
|
US6124314A
(en)
|
1997-10-10 |
2000-09-26 |
Pfizer Inc. |
Osteoporosis compounds
|
|
CA2306837C
(en)
|
1997-10-28 |
2007-05-08 |
Vivus, Inc. |
Treatment of female sexual dysfunction
|
|
AUPP010397A0
(en)
|
1997-10-30 |
1997-11-20 |
Vaisman, Jakov |
Method and composition for treatment of sexual dysfunction
|
|
KR100638684B1
(ko)
|
1997-11-14 |
2006-10-27 |
유나이티드 세러퓨틱스 코오포레이션 |
말초 혈관 질환의 치료를 위한 9-데옥시-2',9-알파-메타노-3-옥사-4,5,6-트리노르-3,7-(1',3'-인터페닐렌)-13,14-디하이드로-프로스타글란딘 에프1의 용도
|
|
US5877211A
(en)
*
|
1997-11-21 |
1999-03-02 |
Allergan |
EP2 receptor agonists as neuroprotective agents for the eye
|
|
CN1282249A
(zh)
|
1997-12-18 |
2001-01-31 |
内森·厄尔·斯科特 |
用于治疗阳痿和增强性唤起的前列腺素E2/F2α组合剂
|
|
US6099870A
(en)
|
1997-12-18 |
2000-08-08 |
Johnson & Johnson Consumer Companies, Inc. |
Methods for improving the health of hair and scalp
|
|
US6436643B1
(en)
|
1997-12-22 |
2002-08-20 |
Unilever Patent Holdings Bv |
Process for site-directed integration of multiple copies of a gene in a mould
|
|
AU1709699A
(en)
|
1997-12-22 |
1999-07-12 |
Alcon Laboratories, Inc. |
13-oxa prostaglandins for the treatment of glaucoma and ocular hypertension
|
|
US5955575A
(en)
|
1997-12-22 |
1999-09-21 |
Hopital Sainte-Justine |
Antagonists of G-protein-coupled receptor
|
|
DE69821987T2
(de)
|
1997-12-25 |
2004-12-16 |
Ono Pharmaceutical Co. Ltd. |
Omega-cycloalkyl-prostaglandin e2 derivate
|
|
GB2330307A
(en)
|
1998-02-07 |
1999-04-21 |
Glaxo Group Ltd |
EP4 Receptor antagonists as bone resorption inhibitors
|
|
EP1071648A2
(de)
|
1998-03-13 |
2001-01-31 |
Merck Frosst Canada & Co. |
CARBONSÄUREN UND ACYLSULFONAMIDE, SOLCHE VERBINDUNGEN ENTHALTENDE Gemenge UND BEHANDLUNGSVERFAHREN
|
|
US6444840B1
(en)
|
1998-03-31 |
2002-09-03 |
The Procter & Gamble Co. |
C11 oxymyl and hydroxylamino prostaglandins useful as FP agonists
|
|
IL138446A0
(en)
|
1998-03-31 |
2001-10-31 |
Procter & Gamble |
C11 oxymyl and hydroxylamino prostaglandins useful as medicaments
|
|
DE69925475T2
(de)
|
1998-03-31 |
2005-11-17 |
Duke University |
C11 oxymyl- und hydroxylamino-prostaglandine verwendbar als fp-agonisten
|
|
CA2334355C
(en)
|
1998-05-25 |
2009-01-27 |
Taisho Pharmaceutical Co., Ltd. |
Prostaglandin derivatives
|
|
US6458549B2
(en)
|
1998-06-11 |
2002-10-01 |
Winthrop-University Hospital |
Methods of diagnosing renal salt wasting syndrome and Alzheimer's disease and methods of treating the same
|
|
US5942545A
(en)
|
1998-06-15 |
1999-08-24 |
Macrochem Corporation |
Composition and method for treating penile erectile dysfunction
|
|
US6187818B1
(en)
|
1998-06-17 |
2001-02-13 |
Pharmacia & Upjohn Company |
Prostaglandins formulation and process
|
|
WO2000002450A1
(en)
|
1998-07-08 |
2000-01-20 |
Fibrogen, Inc. |
Method for treatment of fibrosis related diseases by the administration of prostacyclin derivatives
|
|
BR9906597A
(pt)
|
1998-07-14 |
2000-07-18 |
Alcon Lab Inc |
Produto de prostaglandina
|
|
TWI249520B
(en)
|
1998-07-15 |
2006-02-21 |
Ono Pharmaceutical Co |
5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient
|
|
AU5114499A
(en)
|
1998-07-21 |
2000-02-14 |
Merck & Co., Inc. |
Ophthalmic compositions for treating ocular hypertension
|
|
JP2002521332A
(ja)
|
1998-07-21 |
2002-07-16 |
メルク エンド カムパニー インコーポレーテッド |
高眼圧治療用眼薬組成物
|
|
US6284234B1
(en)
*
|
1998-08-04 |
2001-09-04 |
Johnson & Johnson Consumer Companies, Inc. |
Topical delivery systems for active agents
|
|
AU5196699A
(en)
|
1998-08-12 |
2000-03-06 |
Kazusa Dna Research Institute Foundation |
Novel gene and protein pgth encoded thereby
|
|
US6586468B1
(en)
|
1998-09-14 |
2003-07-01 |
Ono Pharmaceutical Co., Ltd. |
ω-substituted phenyl-prostaglandin E derivatives and drugs containing the same as the active ingredient
|
|
AUPP608898A0
(en)
|
1998-09-23 |
1998-10-15 |
Fujisawa Pharmaceutical Co., Ltd. |
New use of prostaglandin E2 antagonists
|
|
US6121253A
(en)
|
1998-11-20 |
2000-09-19 |
Merck Frosst Canada & Co. |
Prostaglandin conjugates for treating or preventing bone disease
|
|
HK1044532A1
(zh)
|
1999-03-01 |
2002-10-25 |
辉瑞产品公司 |
用作甲状腺受体配体的草氨酸及衍生物
|
|
ATE281432T1
(de)
|
1999-03-05 |
2004-11-15 |
Univ Duke |
C-16 ungesätigte fp-selektive prostaglandin analoge
|
|
AU763715B2
(en)
|
1999-03-05 |
2003-07-31 |
Duke University |
C16 unsaturated fp-selective prostaglandins analogs
|
|
US6894175B1
(en)
|
1999-08-04 |
2005-05-17 |
The Procter & Gamble Company |
2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
|
|
DE60003435T2
(de)
|
1999-08-04 |
2004-05-19 |
The Procter & Gamble Company, Cincinnati |
Neue 2-decarboxy-2-phosphinico prostaglandin f analoge
|
|
KR20020063280A
(ko)
|
1999-12-30 |
2002-08-01 |
더 프록터 앤드 갬블 캄파니 |
생분해성 플라스틱 요식업 품목
|
|
US6548535B2
(en)
|
2000-01-18 |
2003-04-15 |
Merck & Co., Inc. |
Method for treating ocular hypertension
|
|
IL143477A
(en)
|
2001-05-31 |
2009-07-20 |
Finetech Pharmaceutical Ltd |
Process for the preparation of 17-phenyl-18,19,20-trinor-pgf2?? and its derivatives
|
|
WO2001072268A1
(en)
*
|
2000-03-31 |
2001-10-04 |
Toray Industries, Inc. |
Hair growth or hair formation controlling agents
|
|
US20020146439A1
(en)
|
2000-03-31 |
2002-10-10 |
Delong Mitchell Anthony |
Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
|
|
US20020172693A1
(en)
|
2000-03-31 |
2002-11-21 |
Delong Michell Anthony |
Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
|
|
US20020037914A1
(en)
|
2000-03-31 |
2002-03-28 |
Delong Mitchell Anthony |
Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
|
|
US20020013294A1
(en)
|
2000-03-31 |
2002-01-31 |
Delong Mitchell Anthony |
Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
|
|
FR2812193B1
(fr)
|
2000-07-28 |
2003-10-24 |
Oreal |
Utilisation d'antagoniste des recepteurs des prostaglandines ep-2 et/ou ep-4 pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
|
|
FR2812190B1
(fr)
*
|
2000-07-28 |
2003-01-31 |
Oreal |
Utilisation d'agonistes non prostanoiques des recepteurs des prostaglandines ep-2 et/ou ep-4 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
|
|
FR2812191B1
(fr)
|
2000-07-28 |
2003-10-17 |
Oreal |
Utilisation d'agonistes du recepteur des prostaglandines e2 (ep-3) pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
|
|
EP1298223A3
(de)
|
2001-09-28 |
2003-07-23 |
Pfizer Products Inc. |
Methoden die mit der A-C Wiederholungs-Z-Sequenz stromaufwärts des Aldosereduktasegens in Zusammenhang stehen
|
|
US20040082013A1
(en)
|
2002-01-24 |
2004-04-29 |
Regan John W |
Methods for screening for substances which inhibit fp prostanoid receptor interaction with a compound having pgf2alpha activity and methods of treating cancer
|
|
US7351404B2
(en)
|
2002-02-04 |
2008-04-01 |
Allergan, Inc. |
Method of enhancing hair growth
|
|
US7186707B2
(en)
|
2002-04-01 |
2007-03-06 |
University Of Florida |
Prodrugs for use as ophthalmic agents
|
|
GB0208785D0
(en)
|
2002-04-17 |
2002-05-29 |
Medical Res Council |
Treatment methtods
|
|
US7320967B2
(en)
*
|
2002-04-23 |
2008-01-22 |
L'oreal |
Cosmetic composition, method of cosmetic treatment and preparation of a composition for promoting the growth and/or preventing or delaying the loss of hair
|
|
US6573294B1
(en)
|
2002-05-14 |
2003-06-03 |
Allergan, Inc. |
8-azaprostaglandin analogs as agents for lowering intraocular pressure
|
|
US7521530B2
(en)
|
2002-06-11 |
2009-04-21 |
Universite De Montreal |
Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor
|
|
US20030199590A1
(en)
|
2002-07-25 |
2003-10-23 |
Cagle Gerald D |
Prostaglandin analogues for promotion of hair growth
|
|
JP4300833B2
(ja)
|
2003-03-17 |
2009-07-22 |
ソニー株式会社 |
半導体発光素子の製造方法
|
|
US7589233B2
(en)
|
2003-07-29 |
2009-09-15 |
Signature R&D Holdings, Llc |
L-Threonine derivatives of high therapeutic index
|
|
US7045634B2
(en)
|
2003-09-05 |
2006-05-16 |
Allergan, Inc. |
Prostamide receptor antagonists
|
|
US20050058614A1
(en)
*
|
2003-09-15 |
2005-03-17 |
Allergan, Inc. |
Methods for the treatment of gray hair using cyclopentane(ene) heptan(en)oic acid amides
|
|
US7070768B2
(en)
*
|
2003-09-25 |
2006-07-04 |
Allergan, Inc. |
Method for imparting artificial tan to human skin
|
|
US20050112075A1
(en)
|
2003-11-25 |
2005-05-26 |
Hwang Cheng S. |
Reduction of hair growth
|
|
JP2007512347A
(ja)
|
2003-11-26 |
2007-05-17 |
デューク・ユニバーシティー |
緑内障を予防するかまたは治療する方法
|
|
US7288029B1
(en)
|
2005-01-19 |
2007-10-30 |
Gkn Driveline North America, Inc. |
Propshaft with crash-worthiness
|
|
EP1812017A2
(de)
|
2004-10-21 |
2007-08-01 |
Duke University |
Ophthalmologische arzneimittel
|
|
GB0506759D0
(en)
|
2005-04-02 |
2005-05-11 |
Medical Res Council |
Combination treatment methods
|
|
WO2007123818A2
(en)
|
2006-04-18 |
2007-11-01 |
Nitromed, Inc. |
Organic nitric oxide enhancing salts of prostaglandins, compositions and methods of use
|
|
KR101281965B1
(ko)
|
2006-04-24 |
2013-07-03 |
제이에스알 가부시끼가이샤 |
중합체 및 이를 함유하는 감광성 수지 조성물
|
|
US20070254920A1
(en)
|
2006-04-26 |
2007-11-01 |
Aerie Pharmaceuticals, Inc. |
Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
|
|
US7868032B2
(en)
|
2006-10-18 |
2011-01-11 |
Allergan, Inc. |
Prostamide receptor antagonists
|
|
JP5095269B2
(ja)
|
2007-06-05 |
2012-12-12 |
北海道エア・ウォーター株式会社 |
通信システム
|
|
US20090018204A1
(en)
|
2007-07-13 |
2009-01-15 |
Brinkenhoff Michael C |
Composition and method for enhancing hair growth
|
|
US8722739B2
(en)
|
2008-10-29 |
2014-05-13 |
Novaer Holdings, Inc. |
Amino acid salts of prostaglandins
|
|
US8623918B2
(en)
|
2008-10-29 |
2014-01-07 |
Novaer Holdings, Inc. |
Amino acid salts of prostaglandins
|
|
CA2739571A1
(en)
|
2008-10-29 |
2010-08-26 |
Aerie Pharmaceuticals, Inc. |
Amino acid salts of prostaglandins
|
|
WO2010108012A1
(en)
|
2009-03-18 |
2010-09-23 |
Duke University |
Compositions and methods for promoting nasal patency and treating neurogenic bladder using prostaglandins
|
|
JP5331025B2
(ja)
|
2010-02-18 |
2013-10-30 |
八千代工業株式会社 |
サンルーフ装置のガイドパイプの保持構造
|